IKang Guobin Healthcare Group Submitted Application To The SEC For Nasdaq IPO
This article was originally published in PharmAsia News
Executive Summary
Ikang Guobin Healthcare Group, a medical examination and health management service provider, has submitted its IPO application to U.S. SEC to be listed on NASDAQ, aiming to raise up to $150 million during its IPO.